When making a PT 141 peptide purchase for laboratory research, selecting analytical-grade Bremelanotide with verified purity is critical for reproducibility. PX1 Research supplies high-purity PT-141 synthesized in GMP-compliant USA facilities, backed by lot-specific RP-HPLC, mass spectrometry analysis, and strict endotoxin testing for in vitro and animal studies.
When making a PT 141 peptide purchase for laboratory research, selecting analytical-grade Bremelanotide with verified purity is critical for reproducibility. PX1 Research supplies high-purity PT-141 synthesized in GMP-compliant USA facilities, backed by lot-specific RP-HPLC, mass spectrometry analysis, and strict endotoxin testing for in vitro and animal studies.
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Structurally derived from Melanotan II, PT-141 features the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH and a molecular weight of approximately 1024.2 g/mol. Unlike its parent peptide, Bremelanotide possesses a modified C-terminal structure that selectively alters its receptor binding affinity, reducing its activation of peripheral melanocortin-1 receptors (MC1R) while maintaining high affinity for central melanocortin receptors.
Investigators making a PT-141 peptide purchase for comparative receptor assays rely on chemical stability and precise structural conformation. The cyclic lactam bridge between the Asp and Lys residues imparts significant resistance to enzymatic degradation by serum proteases in preclinical models. This structural rigidity ensures consistent binding kinetics during competitive ligand assays and receptor-transfection studies in laboratory settings.
The primary mechanism of action for PT-141 involves potent agonism of central melanocortin receptors, predominantly the MC3R and MC4R subtypes expressed within the central nervous system. In vitro binding studies demonstrate that Bremelanotide acts as a full agonist at human MC4R, initiating intracellular cyclic adenosine monophosphate (cAMP) accumulation through G-protein coupled receptor (GPCR) signal transduction pathways.
Unlike vascular-active small molecules that modulate phosphodiesterase (PDE-5) enzymatic pathways peripherally, PT-141 exerts its primary effects via central neural networks. Preclinical models indicate that activation of medial preoptic area (mPOA) and paraventricular nucleus (PVN) melanocortin receptors by PT-141 triggers downstream dopaminergic pathways. Researchers studying melanocortin receptor agonists utilize this compound to map central regulatory circuits governing autonomic and neuroendocrine responses.
In animal models, PT-141 has been extensively evaluated for its role in modulating neurobehavioral responses linked to sexual-health pathways. Rodent studies evaluating appetitive and consummatory sexual behaviors demonstrate that central administration of Bremelanotide induces dose-dependent lordosis in female models and spontaneous penile erections in male models, independent of nitric oxide donor activity. These responses persist in sympathectomized animal subjects, reinforcing the hypothesis of a central central nervous system mediator.
Comparative preclinical literature published in peer-reviewed journals demonstrates that PT-141 crosses the blood-brain barrier via passive diffusion and transport mechanisms when evaluated in cell culture BBB models. Investigators accessing the PX1 research library hub can examine trial data illustrating how Bremelanotide alters c-Fos expression in hypothalamic sub-regions, providing a cellular marker for neuronal activation following agonist application.
For laboratory experiments to yield publication-grade data, synthetic peptides must be free of residual truncation sequences, deletion peptides, and organic solvents. Every lot offered for PT-141 peptide purchase at PX1 Research undergoes rigorous testing via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to guarantee a chemical purity profile exceeding 98.0%.
To confirm exact molecular mass and sequence identity, Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or electrospray ionization mass spectrometry (ESI-MS) is performed on every batch. The resulting Certificate of Analysis (COA) provides researchers with comprehensive spectral verification, ensuring that experimental variables are not confounded by peptide synthesis artifacts or counter-ion variations such as excess trifluoroacetate (TFA).
Bacterial endotoxins (lipopolysaccharides) represent a critical confounding variable in cell culture assays and animal studies, capable of inducing non-specific inflammatory cytokines, altering microvascular tone, and causing cell mortality. PX1 Research subjects all peptide lots to quantitative Limulus Amebocyte Lysate (LAL) chromogenic assays to verify endotoxin levels remain strictly below <0.01 EU/mg.
All synthesis and purification procedures are conducted in ISO 17025 accredited analytical laboratories operating under strict GMP-compliant quality management systems. This level of quality control ensures that researchers conducting sensitive in vitro signaling studies or in vivo microdialysis receive research-grade material free from biological contaminants.
When designing comparative signaling experiments, researchers frequently evaluate PT-141 alongside other peptide ligands targeting neuroendocrine and behavioral pathways. Understanding the structural and functional distinctions between these compounds is vital for selective receptor mapping.
While PT-141 acts selectively as an MC3R/MC4R agonist with minimal affinity for MC1R, its predecessor Melanotan II exhibits non-selective agonism across MC1R, MC3R, MC4R, and MC5R, frequently producing melanogenesis alongside central signaling responses. In contrast, non-melanocortin research compounds such as Oxytocin target neurohypophyseal nonapeptide receptors to modulate social bonding and smooth muscle contraction, while Kisspeptin-10 acts upstream on GPR54 to trigger gonadotropin-releasing hormone (GnRH) pulse generation. Evaluating these distinct pharmacological profiles allows research facilities to isolate central melanocortin pathways from gonadotropic or oxytocinergic cascades.
PT-141 is supplied as a lyophilized (freeze-dried) powder to maximize shelf stability during transit and storage. For optimal preservation, unconstituted vials should be stored at -20°C in a dry environment protected from light. Under these conditions, the desiccated peptide retains chemical stability for up to 24 months.
When preparing PT-141 for laboratory assays, reconstitution should be performed using sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). Following our standard peptide reconstitution guide, the solvent should be introduced gently along the glass vial wall without violent agitation to prevent shear stress and peptide denaturation. Reconstituted solutions should be aliquoted into single-use polypropylene tubes and stored at -80°C to minimize freeze-thaw degradation cycles.
Procuring research compounds for academic or institutional laboratories requires complete transparency and supply chain traceability. PX1 Research differentiates itself by maintaining 100% USA-based manufacturing, avoiding third-party grey-market re-packaging. Every single lot is linked to a publicly accessible, verifiable Certificate of Analysis from an independent ISO 17025 testing facility.
In addition to analytical rigor, PX1 Research provides rapid fulfillment to prevent laboratory operational downtime. Orders ship same-day (Monday through Friday) directly from dual distribution hubs located in California and Arizona. Institutional procurement departments seeking consistent batch-to-batch reproducibility rely on PX1 for reliable supply and rigorous quality documentation.
Principal investigators, university laboratories, and contract research organizations (CROs) requiring large-scale synthesis or bulk lot reservations can establish dedicated supply pipelines. Managing longitudinal studies requires consistent batch parameters to eliminate lot-to-lot variance across extended experimental timelines.
PX1 Research accommodates high-volume procurement through streamlined wholesale lab accounts. Institutional clients receive dedicated account management, custom synthesis capabilities, bulk pricing tiers, and prioritized analytical testing packages tailored to specific experimental protocols.
What is PT-141 (Bremelanotide) used for in laboratory settings?
PT-141 is investigated in preclinical research to study melanocortin-receptor signaling (specifically MC3R and MC4R), central nervous system control of autonomic responses, dopaminergic pathway activation, and neuroendocrine regulation linked to sexual-health pathways.
What analytical documentation accompanies a PT 141 peptide purchase from PX1 Research?
Every lot of PT-141 includes a lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory. Documentation includes RP-HPLC chromatograms confirming >98% purity, mass spectrometry (MS) sequence confirmation, and quantitative LAL endotoxin test results.
Is PT-141 supplied by PX1 Research intended for human consumption?
No. All products sold by PX1 Research, including PT-141, are strictly for laboratory research, in vitro assays, and preclinical animal studies. They are explicitly not for human or veterinary use, medical treatment, or clinical administration.
How does PT-141 differ from Melanotan II in receptor binding studies?
While Melanotan II is a non-selective melanocortin receptor agonist that activates MC1R, MC3R, MC4R, and MC5R (inducing skin pigmentation via MC1R), PT-141 is a structural derivative that exhibits selective binding primarily to MC3R and MC4R with significantly diminished MC1R activity.
What are the recommended reconstitution parameters for PT-141?
Lyophilized PT-141 should be reconstituted under aseptic conditions using sterile bacteriostatic water or buffered laboratory saline. Reagents should be added slowly along the vial wall and allowed to dissolve without vigorous shaking to protect structural integrity.
What are the proper storage conditions for lyophilized and reconstituted PT-141?
Lyophilized PT-141 powder should be stored at -20°C to -80°C in a desiccated, light-protected environment. Once reconstituted into liquid solution, aliquots should be frozen at -80°C to avoid repeated freeze-thaw cycles.
What is the endotoxin limit guaranteed for PX1 Research PT-141?
PX1 Research guarantees that all lots of PT-141 test below <0.01 EU/mg for bacterial endotoxins via standardized LAL assay, ensuring suitability for cell culture and sensitive animal models.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in GMP-compliant facilities within the United States. Orders are dispatched same-day (Monday–Friday) from primary logistics hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.